Background Thrombocytopenia and platelet indices in COVID-19 patients were important for
prompt treatment and management of the disease. Therefore, the main objective of this …

Background Coagulopathy and thromboembolic events are among the complications of
Corona Virus disease 2019 (COVID-19). Abnormal coagulation parameters in COVID-19 …

Introduction: On March 11, 2020, the World Health Organization (WHO) declared SARS-CoV-
19 a pandemic with about 114 countries affected. Many studies and metanalyses have …

Background Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which
causes novel coronavirus disease 2019 (COVID‐19), is spreading rapidly around the world …

Background COVID-19, which is caused by the corona virus 2 that causes severe acute
respiratory syndrome, causes a respiratory and systemic illness that in 10–15% of patients …

Introduction: Multiple lines of evidence have attested that decreased numbers of platelets
may serve as a surrogate marker for poor prognosis in a wide range of infectious diseases …

SUMMARY OBJECTIVE: Coronavirus disease 2019 (COVID-19) is a novel infectious viral
disease that can be associated with changes in platelet counts. Thrombocytopenia is a risk …

Abstract Background Coronavirus disease 2019 (COVID-19) is a novel infectious disease
with lack of established laboratory markers available to evaluate illness severity. In this …

Introduction Platelets are not only involved in hemostasis and coagulation, but play a
significant role in innate immunity and inflammatory response. Excess production of …

Abstract Keywords: COVID-19; platelet count; severe; thrombocytopenia; meta-analysis EN
COVID-19 platelet count severe thrombocytopenia meta-analysis e29 e33 5 07/01/20 …